Evidence map›Paper›PMID 34950676›Full record

SynthesisFrontiers in medicine2021

Prevalence and Prognostic Significance of Hyponatremia in Patients With Lung Cancer: Systematic Review and Meta-Analysis.

Eszter Bartalis, Marin Gergics, Benedek Tinusz, Mária Földi, Szabolcs Kiss, Dávid Németh, Margit Solymár, Zsolt Szakács, Péter Hegyi, Emese Mezösi and 1 more

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Frontiers in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Eszter BartalisMedical School, Institute for Translational Medicine, University of Pécs, Pécs, Hungary.
Marin GergicsFirst Department of Medicine, Medical School, University of Pécs, Pécs, Hungary.
Benedek TinuszMedical School, Institute for Translational Medicine, University of Pécs, Pécs, Hungary.
Mária FöldiMedical School, Institute for Translational Medicine, University of Pécs, Pécs, Hungary.
Szabolcs KissMedical School, Institute for Translational Medicine, University of Pécs, Pécs, Hungary.
Dávid NémethMedical School, Institute for Translational Medicine, University of Pécs, Pécs, Hungary.
Margit SolymárMedical School, Institute for Translational Medicine, University of Pécs, Pécs, Hungary.
Zsolt SzakácsMedical School, Institute for Translational Medicine, University of Pécs, Pécs, Hungary.
Péter HegyiMedical School, Institute for Translational Medicine, University of Pécs, Pécs, Hungary.
Emese MezösiFirst Department of Medicine, Medical School, University of Pécs, Pécs, Hungary.
László BajnokFirst Department of Medicine, Medical School, University of Pécs, Pécs, Hungary.
University of Pecs · HUUniversity of Szeged · HUUniversitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

hyponatremialung cancerNSCLCSCLCSIADH

Identifiers

PMID34950676
PMCPMC8688712
OpenAlexW4200226975

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.